University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

4 Repeat Tauopathy Neuroimaging Initiative

Active, not recruiting

Conditions: Progressive Supranuclear Palsy
Corticobasal Degeneration

Interventions: Other: Observational Study

First Posted Date: 2013-03-05

Last Posted Date: 2024-01-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 110

Registration Number: NCT01804452

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
John Hopkins University, Baltimore, Maryland, United States

Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: SipT Treatment
Drug: Ipilimumab

First Posted Date: 2013-03-05

Last Posted Date: 2021-08-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 50

Registration Number: NCT01804465

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Kidney and Periodontal Disease Study

Not Applicable

Completed

Conditions: Chronic Kidney Disease
Periodontal Disease

Interventions: Procedure: Scaling and root planing
Drug: Minocycline

First Posted Date: 2013-03-01

Last Posted Date: 2019-04-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 51

Registration Number: NCT01802216

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Phase 2

Completed

Conditions: Recurrent Prostate Carcinoma
Stage III Prostate Adenocarcinoma AJCC v7
Prostate Adenocarcinoma
Stage II Prostate Adenocarcinoma AJCC v7
Stage I Prostate Adenocarcinoma AJCC v7

Interventions: Drug: Itraconazole
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study

First Posted Date: 2013-02-08

Last Posted Date: 2020-02-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 21

Registration Number: NCT01787331

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: ivacaftor
Drug: Placebo

First Posted Date: 2013-02-05

Last Posted Date: 2020-09-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT01784419

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Phase 2

Completed

Conditions: Diabetes Mellitus, Insulin-Dependent, 1
Diabetes Mellitus, Type I
Type 1 Diabetes Mellitus
Insulin-Dependent Diabetes Mellitus 1
IDDM

Interventions: Drug: Imatinib Mesylate
Drug: Placebo (For imatinib mesylate)

First Posted Date: 2013-02-01

Last Posted Date: 2020-02-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 67

Registration Number: NCT01781975

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
University of California-San Francisco, San Francisco, California, United States
🇺🇸
Barbara Davis Center, Aurora, Colorado, United States

and more 6 locations

Novel Imaging Markers for Rheumatoid Arthritis

Completed

Conditions: Rheumatoid Arthritis

First Posted Date: 2013-01-23

Last Posted Date: 2018-11-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT01773681

Locations: 🇺🇸
UCSF - China Basin Imaging Center, San Francisco, California, United States

Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease

Phase 1

Completed

Conditions: Sickle Cell Disease

Interventions: Drug: Cannabis

First Posted Date: 2013-01-18

Last Posted Date: 2020-08-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 27

Registration Number: NCT01771731

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

Not Applicable

Completed

Conditions: Kidney Transplantation

Interventions: Other: Dose adjust group (NFAT)

First Posted Date: 2013-01-18

Last Posted Date: 2020-05-21

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT01771705

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study

Not Applicable

Completed

Conditions: Kyphosis

Interventions: Behavioral: Kyphosis spinal strengthening exercises

First Posted Date: 2013-01-11

Last Posted Date: 2019-11-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 112

Registration Number: NCT01766674

Locations: 🇺🇸
UCSF, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy